Rank | Gene Set | Z-score |
---|---|---|
1 | presynaptic membrane assembly (GO:0097105) | 6.01754878 |
2 | presynaptic membrane organization (GO:0097090) | 5.31568591 |
3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.79227073 |
4 | postsynaptic membrane organization (GO:0001941) | 4.72969917 |
5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.46770594 |
6 | short-term memory (GO:0007614) | 4.28316889 |
7 | neuronal action potential propagation (GO:0019227) | 4.26585802 |
8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.97247321 |
9 | vocalization behavior (GO:0071625) | 3.83616296 |
10 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.73927714 |
11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.73527805 |
12 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.70663832 |
13 | protein localization to synapse (GO:0035418) | 3.69131742 |
14 | cAMP catabolic process (GO:0006198) | 3.61575525 |
15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.57517271 |
16 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.55074646 |
17 | cyclic nucleotide catabolic process (GO:0009214) | 3.44386458 |
18 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.39344056 |
19 | mechanosensory behavior (GO:0007638) | 3.37681061 |
20 | neuron cell-cell adhesion (GO:0007158) | 3.36925667 |
21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.31911459 |
22 | regulation of protein kinase A signaling (GO:0010738) | 3.24005972 |
23 | positive regulation of fibroblast migration (GO:0010763) | 3.23449482 |
24 | positive regulation of membrane potential (GO:0045838) | 3.18135404 |
25 | cellular extravasation (GO:0045123) | 3.14896253 |
26 | glutamate receptor signaling pathway (GO:0007215) | 3.12680467 |
27 | angiogenesis involved in wound healing (GO:0060055) | 3.11584612 |
28 | regulation of postsynaptic membrane potential (GO:0060078) | 3.11004019 |
29 | synaptic transmission, glutamatergic (GO:0035249) | 3.08367545 |
30 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.07555500 |
31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.06063124 |
32 | protein localization to endosome (GO:0036010) | 3.04745782 |
33 | neuron-neuron synaptic transmission (GO:0007270) | 3.04288426 |
34 | synaptic vesicle exocytosis (GO:0016079) | 3.03727601 |
35 | B cell receptor signaling pathway (GO:0050853) | 3.00319846 |
36 | long-term memory (GO:0007616) | 2.99925788 |
37 | membrane assembly (GO:0071709) | 2.98563096 |
38 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.97278675 |
39 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.96176535 |
40 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.92102075 |
41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.91905166 |
42 | long-term synaptic potentiation (GO:0060291) | 2.89119062 |
43 | mast cell degranulation (GO:0043303) | 2.88250466 |
44 | mast cell activation involved in immune response (GO:0002279) | 2.88250466 |
45 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.87560495 |
46 | positive regulation of macrophage cytokine production (GO:0060907) | 2.85578543 |
47 | locomotory exploration behavior (GO:0035641) | 2.84922216 |
48 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.84286902 |
49 | positive regulation of Rap GTPase activity (GO:0032854) | 2.83803773 |
50 | L-amino acid import (GO:0043092) | 2.82818450 |
51 | mast cell activation (GO:0045576) | 2.82334931 |
52 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.80581156 |
53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.79735209 |
54 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.77754112 |
55 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.76250732 |
56 | regulation of dendritic spine development (GO:0060998) | 2.75477633 |
57 | negative regulation of phagocytosis (GO:0050765) | 2.74371719 |
58 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.73958391 |
59 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.73273061 |
60 | cellular response to ethanol (GO:0071361) | 2.73270230 |
61 | regulation of macrophage cytokine production (GO:0010935) | 2.69891349 |
62 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.69263986 |
63 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.68239440 |
64 | regulation of glutamate secretion (GO:0014048) | 2.67827719 |
65 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.67808970 |
66 | negative regulation of cell killing (GO:0031342) | 2.67808970 |
67 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.67261634 |
68 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.67261634 |
69 | modulation by symbiont of host immune response (GO:0052553) | 2.67261634 |
70 | positive regulation by symbiont of host defense response (GO:0052509) | 2.67261634 |
71 | modulation by symbiont of host defense response (GO:0052031) | 2.67261634 |
72 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.67261634 |
73 | membrane depolarization (GO:0051899) | 2.65647934 |
74 | macrophage activation involved in immune response (GO:0002281) | 2.64172838 |
75 | establishment of endothelial barrier (GO:0061028) | 2.63984735 |
76 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.63305860 |
77 | auditory behavior (GO:0031223) | 2.61600742 |
78 | glutamate secretion (GO:0014047) | 2.61518052 |
79 | regulation of gamma-delta T cell activation (GO:0046643) | 2.61506618 |
80 | regulation of synaptic plasticity (GO:0048167) | 2.61306203 |
81 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.60873952 |
82 | startle response (GO:0001964) | 2.59615997 |
83 | negative regulation of neurotransmitter transport (GO:0051589) | 2.59092359 |
84 | positive regulation of neurotransmitter transport (GO:0051590) | 2.58959287 |
85 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.58730768 |
86 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.56886412 |
87 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.56846340 |
88 | membrane raft organization (GO:0031579) | 2.56188096 |
89 | negative regulation of amino acid transport (GO:0051956) | 2.53881763 |
90 | nerve growth factor signaling pathway (GO:0038180) | 2.53390801 |
91 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.52911638 |
92 | neutrophil mediated immunity (GO:0002446) | 2.51981435 |
93 | germinal center formation (GO:0002467) | 2.51834929 |
94 | detection of molecule of bacterial origin (GO:0032490) | 2.51416902 |
95 | cellular response to epinephrine stimulus (GO:0071872) | 2.51150489 |
96 | stress fiber assembly (GO:0043149) | 2.50243072 |
97 | cAMP metabolic process (GO:0046058) | 2.49402027 |
98 | response to muramyl dipeptide (GO:0032495) | 2.48801716 |
99 | synaptic vesicle maturation (GO:0016188) | 2.48349461 |
100 | regulation of synaptic vesicle transport (GO:1902803) | 2.48168031 |
101 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.47161190 |
102 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.46229699 |
103 | axon ensheathment in central nervous system (GO:0032291) | 2.45939263 |
104 | central nervous system myelination (GO:0022010) | 2.45939263 |
105 | visual learning (GO:0008542) | 2.45928828 |
106 | regulation of macrophage chemotaxis (GO:0010758) | 2.45524582 |
107 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.45344661 |
108 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.43493658 |
109 | cortical actin cytoskeleton organization (GO:0030866) | 2.43353589 |
110 | regulation of pigment cell differentiation (GO:0050932) | 2.43237476 |
111 | response to histamine (GO:0034776) | 2.42832419 |
112 | serotonin metabolic process (GO:0042428) | 2.42566865 |
113 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.42231538 |
114 | adult walking behavior (GO:0007628) | 2.40286781 |
115 | regulation of ARF protein signal transduction (GO:0032012) | 2.39865352 |
116 | myeloid leukocyte mediated immunity (GO:0002444) | 2.38046609 |
117 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.37919728 |
118 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.36069840 |
119 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.35271509 |
120 | adenosine receptor signaling pathway (GO:0001973) | 2.35236658 |
121 | glycine transport (GO:0015816) | 2.34397850 |
122 | cGMP metabolic process (GO:0046068) | 2.33528354 |
123 | monocyte differentiation (GO:0030224) | 2.32286636 |
124 | associative learning (GO:0008306) | 2.32168466 |
125 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.31719570 |
126 | positive regulation of receptor recycling (GO:0001921) | 2.31491596 |
127 | positive regulation of synaptic transmission (GO:0050806) | 2.30738530 |
128 | surfactant homeostasis (GO:0043129) | 2.30442470 |
129 | vesicle docking involved in exocytosis (GO:0006904) | 2.30028019 |
130 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.29928481 |
131 | phosphorelay signal transduction system (GO:0000160) | 2.29743143 |
132 | regulation of respiratory system process (GO:0044065) | 2.29035365 |
133 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.28746095 |
134 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.27756036 |
135 | response to host (GO:0075136) | 2.27756036 |
136 | response to host defenses (GO:0052200) | 2.27756036 |
137 | positive regulation of dendritic spine development (GO:0060999) | 2.27716504 |
138 | positive thymic T cell selection (GO:0045059) | 2.27043836 |
139 | learning (GO:0007612) | 2.27041294 |
140 | hypotonic response (GO:0006971) | 2.26950001 |
141 | Rap protein signal transduction (GO:0032486) | 2.26114578 |
142 | regulation of Rap GTPase activity (GO:0032317) | 2.25870738 |
143 | growth hormone receptor signaling pathway (GO:0060396) | 2.25226798 |
144 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.25192178 |
145 | negative regulation of growth of symbiont in host (GO:0044130) | 2.24657615 |
146 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.24657615 |
147 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.24657615 |
148 | regulation of growth of symbiont in host (GO:0044126) | 2.24657615 |
149 | detection of other organism (GO:0098543) | 2.24441732 |
150 | response to epinephrine (GO:0071871) | 2.24356789 |
151 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.23309811 |
152 | macrophage activation (GO:0042116) | 2.23045379 |
153 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.22745274 |
154 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.21473770 |
155 | B cell homeostasis (GO:0001782) | 2.21248391 |
156 | response to host immune response (GO:0052572) | 2.18098050 |
157 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.18098050 |
158 | response to interleukin-15 (GO:0070672) | 2.16776912 |
159 | endothelium development (GO:0003158) | 2.16707332 |
160 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.14926395 |
161 | detection of external biotic stimulus (GO:0098581) | 2.14400102 |
162 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.13681793 |
163 | negative regulation of anoikis (GO:2000811) | 2.13287683 |
164 | mannose metabolic process (GO:0006013) | 2.13268815 |
165 | T cell migration (GO:0072678) | 2.10246107 |
166 | regulation of protein polyubiquitination (GO:1902914) | 2.09608453 |
167 | blood vessel maturation (GO:0001955) | 2.09038260 |
168 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.08366325 |
169 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.07470638 |
170 | negative regulation of interleukin-12 production (GO:0032695) | 2.07078960 |
171 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.06039578 |
172 | negative thymic T cell selection (GO:0045060) | 2.05945461 |
173 | mRNA transcription (GO:0009299) | 2.05665892 |
174 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.05629126 |
175 | cortical cytoskeleton organization (GO:0030865) | 2.05601120 |
176 | negative regulation of fatty acid transport (GO:2000192) | 2.05297624 |
177 | microglial cell activation (GO:0001774) | 2.04749187 |
178 | regulation of fibroblast migration (GO:0010762) | 2.02609799 |
179 | response to peptidoglycan (GO:0032494) | 2.02091864 |
180 | response to type I interferon (GO:0034340) | 2.01869219 |
181 | sprouting angiogenesis (GO:0002040) | 2.01351146 |
182 | cell volume homeostasis (GO:0006884) | 2.01237200 |
183 | regulation of extracellular matrix disassembly (GO:0010715) | 2.00611762 |
184 | focal adhesion assembly (GO:0048041) | 2.00452241 |
185 | cell-substrate adherens junction assembly (GO:0007045) | 2.00452241 |
186 | phospholipid translocation (GO:0045332) | 1.99071835 |
187 | lipid translocation (GO:0034204) | 1.99071835 |
188 | regulation of T-helper 2 cell differentiation (GO:0045628) | 1.98719450 |
189 | cellular response to growth hormone stimulus (GO:0071378) | 1.98603282 |
190 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 1.98522451 |
191 | detection of bacterium (GO:0016045) | 1.98226345 |
192 | type I interferon signaling pathway (GO:0060337) | 1.98205726 |
193 | cellular response to type I interferon (GO:0071357) | 1.98205726 |
194 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 1.97726275 |
195 | negative T cell selection (GO:0043383) | 1.97002583 |
196 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 1.96681921 |
197 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 1.95395070 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.13222041 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.87290488 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.27286192 |
4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.93121982 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.53692698 |
6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.50614080 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.47809971 |
8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.30568031 |
9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.22593353 |
10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.20966172 |
11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.20062696 |
12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18960366 |
13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.13956060 |
14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13769634 |
15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.12154520 |
16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.10776680 |
17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.10776680 |
18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.10204384 |
19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.08121154 |
20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.01022870 |
21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.98077996 |
22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.96914042 |
23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92769207 |
24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.92478247 |
25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.92156569 |
26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89858184 |
27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.86630677 |
28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.83849786 |
29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.81887742 |
30 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.78573093 |
31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.77136935 |
32 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.74309665 |
33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.74297041 |
34 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71402367 |
35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.67834840 |
36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63779182 |
37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61343118 |
38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58277984 |
39 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.57695754 |
40 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.56879112 |
41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.56004923 |
42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55277373 |
43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53439540 |
44 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.52538096 |
45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51728697 |
46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50525857 |
47 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49639294 |
48 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49048293 |
49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48399089 |
50 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46828360 |
51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46374657 |
52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.45901607 |
53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45842998 |
54 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45547829 |
55 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.44937520 |
56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43101463 |
57 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.42110840 |
58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40528933 |
59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.39915067 |
60 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38164472 |
61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37037573 |
62 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.36455137 |
63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35970006 |
64 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.33637381 |
65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32658787 |
66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32585523 |
67 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32098625 |
68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32085994 |
69 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31969800 |
70 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.31838777 |
71 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.31798860 |
72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.31368772 |
73 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.29611219 |
74 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29202490 |
75 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.28912930 |
76 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.28674596 |
77 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28147813 |
78 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27443618 |
79 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27414350 |
80 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26642747 |
81 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26307086 |
82 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25686707 |
83 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.25241072 |
84 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25191500 |
85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.24033770 |
86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.24033770 |
87 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23857534 |
88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23466969 |
89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23271690 |
90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23048360 |
91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22935778 |
92 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22346826 |
93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22234739 |
94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22119119 |
95 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.21167503 |
96 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.21065510 |
97 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20386026 |
98 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20117553 |
99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19736542 |
100 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19729381 |
101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.19630253 |
102 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.18950383 |
103 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18871893 |
104 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.18529824 |
105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18489377 |
106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18387069 |
107 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.17349061 |
108 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.17083678 |
109 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.16212259 |
110 | MYB_26560356_Chip-Seq_TH2_Human | 1.15923739 |
111 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.15830297 |
112 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.15787794 |
113 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15318435 |
114 | GATA2_19941826_ChIP-Seq_K562_Human | 1.14472657 |
115 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.13796785 |
116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13225214 |
117 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12675449 |
118 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.12663029 |
119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12548734 |
120 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11859576 |
121 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.11303827 |
122 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10896549 |
123 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10684061 |
124 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10570961 |
125 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10269313 |
126 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09827157 |
127 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09267654 |
128 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.07541724 |
129 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07431136 |
130 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07225170 |
131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07225170 |
132 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06155657 |
133 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.05725245 |
134 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.05222090 |
135 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.05114558 |
136 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05103172 |
137 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04199115 |
138 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03611331 |
139 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.03419869 |
140 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01548469 |
141 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00519245 |
142 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99667371 |
143 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99651323 |
144 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99214397 |
145 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.99172543 |
146 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99093640 |
147 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98994171 |
148 | MYB_26560356_Chip-Seq_TH1_Human | 0.98779945 |
149 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.98678573 |
150 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98555665 |
151 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98555665 |
152 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98453879 |
153 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98112321 |
154 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98063060 |
155 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97938924 |
156 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.97522535 |
157 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96819859 |
158 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96777400 |
159 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.96136485 |
160 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95361981 |
161 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95121786 |
162 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94317654 |
163 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.94014543 |
164 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93161206 |
165 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91492189 |
166 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91053241 |
167 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90909146 |
168 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90840954 |
169 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89920891 |
170 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88735068 |
171 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88122894 |
172 | MYC_22102868_ChIP-Seq_BL_Human | 0.86567506 |
173 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86465593 |
174 | MAF_26560356_Chip-Seq_TH1_Human | 0.85755514 |
175 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.84106405 |
176 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.83564991 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 4.34313816 |
2 | MP0005409_darkened_coat_color | 3.91197421 |
3 | MP0004859_abnormal_synaptic_plasticity | 3.47484989 |
4 | MP0001188_hyperpigmentation | 3.29224012 |
5 | MP0003300_gastrointestinal_ulcer | 3.18786614 |
6 | MP0003136_yellow_coat_color | 3.03922401 |
7 | MP0008438_abnormal_cutaneous_collagen | 2.65250653 |
8 | MP0003635_abnormal_synaptic_transmissio | 2.53675537 |
9 | MP0009745_abnormal_behavioral_response | 2.52513396 |
10 | MP0005171_absent_coat_pigmentation | 2.45905384 |
11 | MP0003724_increased_susceptibility_to | 2.44263783 |
12 | MP0003303_peritoneal_inflammation | 2.43994911 |
13 | MP0000015_abnormal_ear_pigmentation | 2.40603867 |
14 | MP0001968_abnormal_touch/_nociception | 2.38231780 |
15 | MP0002064_seizures | 2.34937419 |
16 | MP0009046_muscle_twitch | 2.32673711 |
17 | MP0000685_abnormal_immune_system | 2.29566941 |
18 | MP0003091_abnormal_cell_migration | 2.26512366 |
19 | MP0001958_emphysema | 2.22634419 |
20 | MP0002272_abnormal_nervous_system | 2.09136474 |
21 | MP0001486_abnormal_startle_reflex | 2.04782026 |
22 | MP0010368_abnormal_lymphatic_system | 2.02974145 |
23 | MP0003566_abnormal_cell_adhesion | 2.02927821 |
24 | MP0002877_abnormal_melanocyte_morpholog | 2.00383734 |
25 | MP0005174_abnormal_tail_pigmentation | 1.96423233 |
26 | MP0004270_analgesia | 1.90253564 |
27 | MP0002063_abnormal_learning/memory/cond | 1.89856041 |
28 | MP0003705_abnormal_hypodermis_morpholog | 1.88632982 |
29 | MP0003950_abnormal_plasma_membrane | 1.88445201 |
30 | MP0004381_abnormal_hair_follicle | 1.87963634 |
31 | MP0002572_abnormal_emotion/affect_behav | 1.86067203 |
32 | MP0010352_gastrointestinal_tract_polyps | 1.81521340 |
33 | MP0003436_decreased_susceptibility_to | 1.80478520 |
34 | MP0000920_abnormal_myelination | 1.75284902 |
35 | MP0002067_abnormal_sensory_capabilities | 1.73624557 |
36 | MP0004742_abnormal_vestibular_system | 1.73137628 |
37 | MP0008569_lethality_at_weaning | 1.71897410 |
38 | MP0003279_aneurysm | 1.70764628 |
39 | MP0002736_abnormal_nociception_after | 1.69848050 |
40 | MP0003763_abnormal_thymus_physiology | 1.66784785 |
41 | MP0002876_abnormal_thyroid_physiology | 1.59758162 |
42 | MP0002006_tumorigenesis | 1.58817241 |
43 | MP0001501_abnormal_sleep_pattern | 1.57920070 |
44 | MP0005275_abnormal_skin_tensile | 1.57561685 |
45 | MP0005646_abnormal_pituitary_gland | 1.48410293 |
46 | MP0002735_abnormal_chemical_nociception | 1.47267239 |
47 | MP0003191_abnormal_cellular_cholesterol | 1.45710740 |
48 | MP0002138_abnormal_hepatobiliary_system | 1.45579448 |
49 | MP0000569_abnormal_digit_pigmentation | 1.43461068 |
50 | MP0004147_increased_porphyrin_level | 1.42528867 |
51 | MP0003183_abnormal_peptide_metabolism | 1.40042617 |
52 | MP0008260_abnormal_autophagy | 1.37425900 |
53 | MP0001879_abnormal_lymphatic_vessel | 1.35671567 |
54 | MP0005423_abnormal_somatic_nervous | 1.35513058 |
55 | MP0002734_abnormal_mechanical_nocicepti | 1.34542871 |
56 | MP0009780_abnormal_chondrocyte_physiolo | 1.33524011 |
57 | MP0003690_abnormal_glial_cell | 1.33180651 |
58 | MP0003879_abnormal_hair_cell | 1.32270305 |
59 | MP0004947_skin_inflammation | 1.31836715 |
60 | MP0004142_abnormal_muscle_tone | 1.31668866 |
61 | MP0000767_abnormal_smooth_muscle | 1.31630775 |
62 | MP0003633_abnormal_nervous_system | 1.30546984 |
63 | MP0002822_catalepsy | 1.29985056 |
64 | MP0001970_abnormal_pain_threshold | 1.28742610 |
65 | MP0002933_joint_inflammation | 1.25755900 |
66 | MP0002419_abnormal_innate_immunity | 1.25668137 |
67 | MP0000013_abnormal_adipose_tissue | 1.25294452 |
68 | MP0004130_abnormal_muscle_cell | 1.24119066 |
69 | MP0003045_fibrosis | 1.23369039 |
70 | MP0005671_abnormal_response_to | 1.22318085 |
71 | MP0008874_decreased_physiological_sensi | 1.21561992 |
72 | MP0005023_abnormal_wound_healing | 1.19020066 |
73 | MP0001986_abnormal_taste_sensitivity | 1.18364911 |
74 | MP0005670_abnormal_white_adipose | 1.14715460 |
75 | MP0004883_abnormal_blood_vessel | 1.14455522 |
76 | MP0002009_preneoplasia | 1.13881761 |
77 | MP0000249_abnormal_blood_vessel | 1.13270653 |
78 | MP0004084_abnormal_cardiac_muscle | 1.13177329 |
79 | MP0001835_abnormal_antigen_presentation | 1.10490443 |
80 | MP0005058_abnormal_lysosome_morphology | 1.08955648 |
81 | MP0006054_spinal_hemorrhage | 1.06783565 |
82 | MP0004036_abnormal_muscle_relaxation | 1.06305786 |
83 | MP0003787_abnormal_imprinting | 1.06031694 |
84 | MP0002168_other_aberrant_phenotype | 1.06008302 |
85 | MP0009785_altered_susceptibility_to | 1.05350099 |
86 | MP0002095_abnormal_skin_pigmentation | 1.04856414 |
87 | MP0005165_increased_susceptibility_to | 1.04720534 |
88 | MP0001440_abnormal_grooming_behavior | 1.04716525 |
89 | MP0002405_respiratory_system_inflammati | 1.04245271 |
90 | MP0003631_nervous_system_phenotype | 1.02815551 |
91 | MP0005000_abnormal_immune_tolerance | 1.01833470 |
92 | MP0002557_abnormal_social/conspecific_i | 1.01507986 |
93 | MP0006082_CNS_inflammation | 1.01374387 |
94 | MP0002398_abnormal_bone_marrow | 1.00356684 |
95 | MP0000751_myopathy | 1.00129727 |
96 | MP0002733_abnormal_thermal_nociception | 1.00089234 |
97 | MP0005166_decreased_susceptibility_to | 0.99796884 |
98 | MP0009115_abnormal_fat_cell | 0.98738205 |
99 | MP0010155_abnormal_intestine_physiology | 0.98030532 |
100 | MP0001905_abnormal_dopamine_level | 0.97673514 |
101 | MP0000716_abnormal_immune_system | 0.96924140 |
102 | MP0005310_abnormal_salivary_gland | 0.96657498 |
103 | MP0000003_abnormal_adipose_tissue | 0.96576195 |
104 | MP0003075_altered_response_to | 0.95797949 |
105 | MP0001845_abnormal_inflammatory_respons | 0.95696866 |
106 | MP0001502_abnormal_circadian_rhythm | 0.95652852 |
107 | MP0000465_gastrointestinal_hemorrhage | 0.95595341 |
108 | MP0005375_adipose_tissue_phenotype | 0.93653479 |
109 | MP0006138_congestive_heart_failure | 0.93355092 |
110 | MP0004272_abnormal_basement_membrane | 0.92880023 |
111 | MP0003868_abnormal_feces_composition | 0.92792753 |
112 | MP0002148_abnormal_hypersensitivity_rea | 0.91162217 |
113 | MP0004808_abnormal_hematopoietic_stem | 0.90651178 |
114 | MP0005075_abnormal_melanosome_morpholog | 0.89632501 |
115 | MP0006292_abnormal_olfactory_placode | 0.89276104 |
116 | MP0002396_abnormal_hematopoietic_system | 0.88615633 |
117 | MP0005666_abnormal_adipose_tissue | 0.87438996 |
118 | MP0004811_abnormal_neuron_physiology | 0.87214357 |
119 | MP0002420_abnormal_adaptive_immunity | 0.86856933 |
120 | MP0005076_abnormal_cell_differentiation | 0.86685010 |
121 | MP0008004_abnormal_stomach_pH | 0.86652606 |
122 | MP0001963_abnormal_hearing_physiology | 0.86447115 |
123 | MP0005164_abnormal_response_to | 0.85443732 |
124 | MP0008877_abnormal_DNA_methylation | 0.84764460 |
125 | MP0001819_abnormal_immune_cell | 0.84569168 |
126 | MP0005464_abnormal_platelet_physiology | 0.84406405 |
127 | MP0001853_heart_inflammation | 0.84353892 |
128 | MP0002971_abnormal_brown_adipose | 0.84175455 |
129 | MP0001177_atelectasis | 0.81828864 |
130 | MP0009840_abnormal_foam_cell | 0.80519001 |
131 | MP0003828_pulmonary_edema | 0.80420029 |
132 | MP0005167_abnormal_blood-brain_barrier | 0.80182860 |
133 | MP0004510_myositis | 0.79319763 |
134 | MP0000604_amyloidosis | 0.79261871 |
135 | MP0004924_abnormal_behavior | 0.78792348 |
136 | MP0005386_behavior/neurological_phenoty | 0.78792348 |
137 | MP0004484_altered_response_of | 0.78724185 |
138 | MP0002066_abnormal_motor_capabilities/c | 0.78069855 |
139 | MP0005623_abnormal_meninges_morphology | 0.77970989 |
140 | MP0001790_abnormal_immune_system | 0.77535790 |
141 | MP0005387_immune_system_phenotype | 0.77535790 |
142 | MP0002166_altered_tumor_susceptibility | 0.76863003 |
143 | MP0002452_abnormal_antigen_presenting | 0.76831006 |
144 | MP0002723_abnormal_immune_serum | 0.76767682 |
145 | MP0005595_abnormal_vascular_smooth | 0.76713902 |
146 | MP0001851_eye_inflammation | 0.76104972 |
147 | MP0008995_early_reproductive_senescence | 0.73769619 |
148 | MP0003172_abnormal_lysosome_physiology | 0.72615599 |
149 | MP0005535_abnormal_body_temperature | 0.71608786 |
150 | MP0002229_neurodegeneration | 0.71464340 |
151 | MP0000343_altered_response_to | 0.71008806 |
152 | MP0005025_abnormal_response_to | 0.70137731 |
153 | MP0001800_abnormal_humoral_immune | 0.69102644 |
154 | MP0002882_abnormal_neuron_morphology | 0.67754921 |
155 | MP0001533_abnormal_skeleton_physiology | 0.66171269 |
156 | MP0005388_respiratory_system_phenotype | 0.66114023 |
157 | MP0002133_abnormal_respiratory_system | 0.66114023 |
158 | MP0000778_abnormal_nervous_system | 0.65843649 |
159 | MP0002998_abnormal_bone_remodeling | 0.64156128 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.44873485 |
2 | Epileptic encephalopathy (HP:0200134) | 3.90353450 |
3 | Aortic aneurysm (HP:0004942) | 3.84591434 |
4 | Febrile seizures (HP:0002373) | 3.78525775 |
5 | Atonic seizures (HP:0010819) | 3.64129094 |
6 | Broad-based gait (HP:0002136) | 3.49121782 |
7 | Focal seizures (HP:0007359) | 3.43377972 |
8 | Gaze-evoked nystagmus (HP:0000640) | 3.39276110 |
9 | Obstructive sleep apnea (HP:0002870) | 3.18012968 |
10 | Papilledema (HP:0001085) | 3.14658959 |
11 | Abnormal hair whorl (HP:0010721) | 2.99220266 |
12 | Thyroid-stimulating hormone excess (HP:0002925) | 2.94826948 |
13 | Protrusio acetabuli (HP:0003179) | 2.92433991 |
14 | Aortic dissection (HP:0002647) | 2.88125789 |
15 | Hyperventilation (HP:0002883) | 2.84886384 |
16 | Myokymia (HP:0002411) | 2.84542064 |
17 | Osteolytic defects of the hand bones (HP:0009699) | 2.78657075 |
18 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.78657075 |
19 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.78646184 |
20 | Agammaglobulinemia (HP:0004432) | 2.77445902 |
21 | Progressive cerebellar ataxia (HP:0002073) | 2.73724132 |
22 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.73458102 |
23 | Absent/shortened dynein arms (HP:0200106) | 2.73458102 |
24 | Sensory axonal neuropathy (HP:0003390) | 2.73188794 |
25 | Gastrointestinal stroma tumor (HP:0100723) | 2.67334309 |
26 | Cerebral aneurysm (HP:0004944) | 2.64705618 |
27 | Vascular tortuosity (HP:0004948) | 2.64478970 |
28 | Recurrent abscess formation (HP:0002722) | 2.63669030 |
29 | Arterial tortuosity (HP:0005116) | 2.60200975 |
30 | Meningitis (HP:0001287) | 2.60055234 |
31 | Hematochezia (HP:0002573) | 2.58857194 |
32 | Interstitial pulmonary disease (HP:0006530) | 2.57605790 |
33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.56230662 |
34 | Obstructive lung disease (HP:0006536) | 2.56230662 |
35 | Blue irides (HP:0000635) | 2.51795353 |
36 | Ocular albinism (HP:0001107) | 2.50531861 |
37 | Absent speech (HP:0001344) | 2.46507264 |
38 | Scanning speech (HP:0002168) | 2.44462488 |
39 | Persistence of primary teeth (HP:0006335) | 2.38276968 |
40 | Emphysema (HP:0002097) | 2.37462502 |
41 | Iris hypopigmentation (HP:0007730) | 2.37152407 |
42 | Generalized tonic-clonic seizures (HP:0002069) | 2.35712230 |
43 | Glucose intolerance (HP:0000833) | 2.35132617 |
44 | Dilatation of the ascending aorta (HP:0005111) | 2.34731940 |
45 | Aneurysm (HP:0002617) | 2.33977252 |
46 | Submucous cleft hard palate (HP:0000176) | 2.31841741 |
47 | Protruding tongue (HP:0010808) | 2.28235926 |
48 | Nonprogressive disorder (HP:0003680) | 2.28070015 |
49 | Dialeptic seizures (HP:0011146) | 2.26736548 |
50 | White forelock (HP:0002211) | 2.26408380 |
51 | Stomatitis (HP:0010280) | 2.26265874 |
52 | Abnormal sex determination (HP:0012244) | 2.25319836 |
53 | Sex reversal (HP:0012245) | 2.25319836 |
54 | Truncal ataxia (HP:0002078) | 2.23489213 |
55 | Absent frontal sinuses (HP:0002688) | 2.22627785 |
56 | Dysmetric saccades (HP:0000641) | 2.21194203 |
57 | Spontaneous hematomas (HP:0007420) | 2.19079388 |
58 | Abnormality of macrophages (HP:0004311) | 2.18344261 |
59 | Dysmetria (HP:0001310) | 2.18156579 |
60 | J-shaped sella turcica (HP:0002680) | 2.16882787 |
61 | Polycythemia (HP:0001901) | 2.14905397 |
62 | Prolonged bleeding time (HP:0003010) | 2.13732366 |
63 | Overgrowth (HP:0001548) | 2.13499213 |
64 | Action tremor (HP:0002345) | 2.12452359 |
65 | Colitis (HP:0002583) | 2.12288220 |
66 | Osteomyelitis (HP:0002754) | 2.12027414 |
67 | Abnormal ciliary motility (HP:0012262) | 2.11837541 |
68 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.11186145 |
69 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.11186145 |
70 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.10833573 |
71 | Vasculitis (HP:0002633) | 2.10671231 |
72 | Bradycardia (HP:0001662) | 2.10469162 |
73 | Mucopolysacchariduria (HP:0008155) | 2.10357874 |
74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10357874 |
75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09797356 |
76 | Increased variability in muscle fiber diameter (HP:0003557) | 2.09610263 |
77 | Dysostosis multiplex (HP:0000943) | 2.09145458 |
78 | Abnormality of the axillary hair (HP:0100134) | 2.08677380 |
79 | Abnormality of secondary sexual hair (HP:0009888) | 2.08677380 |
80 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.07960374 |
81 | Cellulitis (HP:0100658) | 2.06514168 |
82 | Abnormality of binocular vision (HP:0011514) | 2.05578117 |
83 | Diplopia (HP:0000651) | 2.05578117 |
84 | Sleep apnea (HP:0010535) | 2.05008436 |
85 | Striae distensae (HP:0001065) | 2.04715184 |
86 | Patchy hypopigmentation of hair (HP:0011365) | 2.04649727 |
87 | Wormian bones (HP:0002645) | 2.04618423 |
88 | Hypoplasia of the iris (HP:0007676) | 2.02715501 |
89 | Generalized hypopigmentation of hair (HP:0011358) | 2.02243032 |
90 | Generalized hypotonia (HP:0001290) | 2.01231491 |
91 | Recurrent bacterial skin infections (HP:0005406) | 2.00823052 |
92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00731113 |
93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00731113 |
94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00731113 |
95 | Slow saccadic eye movements (HP:0000514) | 2.00639607 |
96 | Pulmonary infiltrates (HP:0002113) | 2.00193340 |
97 | Myocardial infarction (HP:0001658) | 2.00175874 |
98 | Hemiplegia (HP:0002301) | 1.98850957 |
99 | Subacute progressive viral hepatitis (HP:0006572) | 1.97892655 |
100 | Onion bulb formation (HP:0003383) | 1.97042041 |
101 | Increased connective tissue (HP:0009025) | 1.96821827 |
102 | Gingivitis (HP:0000230) | 1.96197166 |
103 | Hyporeflexia of lower limbs (HP:0002600) | 1.94585432 |
104 | Absence seizures (HP:0002121) | 1.94543957 |
105 | Lower limb amyotrophy (HP:0007210) | 1.93487778 |
106 | Restrictive lung disease (HP:0002091) | 1.92483087 |
107 | Recurrent bronchitis (HP:0002837) | 1.92348299 |
108 | Spondylolisthesis (HP:0003302) | 1.92162689 |
109 | Impaired smooth pursuit (HP:0007772) | 1.91769097 |
110 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91474004 |
111 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91474004 |
112 | Conjunctival telangiectasia (HP:0000524) | 1.91426012 |
113 | Joint hemorrhage (HP:0005261) | 1.91192627 |
114 | Increased CSF protein (HP:0002922) | 1.89834778 |
115 | Clumsiness (HP:0002312) | 1.89375595 |
116 | Eosinophilia (HP:0001880) | 1.89371689 |
117 | Optic nerve hypoplasia (HP:0000609) | 1.88935320 |
118 | Menorrhagia (HP:0000132) | 1.88864014 |
119 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.88293924 |
120 | Recurrent viral infections (HP:0004429) | 1.87806893 |
121 | Esophageal varix (HP:0002040) | 1.86889996 |
122 | Dysdiadochokinesis (HP:0002075) | 1.86603306 |
123 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.85604039 |
124 | Mediastinal lymphadenopathy (HP:0100721) | 1.85477397 |
125 | Gingival bleeding (HP:0000225) | 1.83735752 |
126 | Recurrent fungal infections (HP:0002841) | 1.83594859 |
127 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83064867 |
128 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83064867 |
129 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83064867 |
130 | Decreased circulating renin level (HP:0003351) | 1.82680139 |
131 | Eczematoid dermatitis (HP:0000976) | 1.81996925 |
132 | Abnormal glucose tolerance (HP:0001952) | 1.80907006 |
133 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.80326484 |
134 | Panhypogammaglobulinemia (HP:0003139) | 1.80244184 |
135 | Distal lower limb amyotrophy (HP:0008944) | 1.79755144 |
136 | Mitral valve prolapse (HP:0001634) | 1.79747795 |
137 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.78269617 |
138 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.77240820 |
139 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.77240820 |
140 | Genetic anticipation (HP:0003743) | 1.77143162 |
141 | Abnormality of the fingertips (HP:0001211) | 1.76971642 |
142 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.76614387 |
143 | Mitral stenosis (HP:0001718) | 1.76469238 |
144 | IgA deficiency (HP:0002720) | 1.76360868 |
145 | Abnormal eating behavior (HP:0100738) | 1.75528991 |
146 | Premature rupture of membranes (HP:0001788) | 1.75348918 |
147 | Systemic lupus erythematosus (HP:0002725) | 1.75214707 |
148 | Mucosal telangiectasiae (HP:0100579) | 1.74645475 |
149 | Peripheral hypomyelination (HP:0007182) | 1.74479289 |
150 | Abnormality of saccadic eye movements (HP:0000570) | 1.74411058 |
151 | Chronic diarrhea (HP:0002028) | 1.72198008 |
152 | Poor eye contact (HP:0000817) | 1.71594388 |
153 | Hemorrhage of the eye (HP:0011885) | 1.70993779 |
154 | Thrombocytosis (HP:0001894) | 1.70979608 |
155 | Stereotypic behavior (HP:0000733) | 1.70940875 |
156 | Viral hepatitis (HP:0006562) | 1.70815721 |
157 | Rhinitis (HP:0012384) | 1.69892049 |
158 | Chest pain (HP:0100749) | 1.69318694 |
159 | Chronic otitis media (HP:0000389) | 1.68985767 |
160 | Orchitis (HP:0100796) | 1.68776853 |
161 | Fair hair (HP:0002286) | 1.68760584 |
162 | Recurrent skin infections (HP:0001581) | 1.68480781 |
163 | Cervical subluxation (HP:0003308) | 1.68414114 |
164 | Epistaxis (HP:0000421) | 1.68334093 |
165 | Hemoptysis (HP:0002105) | 1.67290843 |
166 | Asymmetric septal hypertrophy (HP:0001670) | 1.67236942 |
167 | Myositis (HP:0100614) | 1.65742937 |
168 | Amyloidosis (HP:0011034) | 1.65528545 |
169 | Inflammation of the large intestine (HP:0002037) | 1.65497705 |
170 | Abnormality of complement system (HP:0005339) | 1.65317617 |
171 | Abnormality of the right ventricle (HP:0001707) | 1.65280868 |
172 | Abnormal platelet volume (HP:0011876) | 1.64959340 |
173 | Abnormality of the frontal sinuses (HP:0002687) | 1.64671072 |
174 | Acrocyanosis (HP:0001063) | 1.64516925 |
175 | Thoracolumbar scoliosis (HP:0002944) | 1.64423684 |
176 | Depression (HP:0000716) | 1.64083647 |
177 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.63226289 |
178 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.63091910 |
179 | T lymphocytopenia (HP:0005403) | 1.62580856 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 8.83416392 |
2 | MKNK2 | 2.95743611 |
3 | FES | 2.76712398 |
4 | EPHA4 | 2.51697371 |
5 | PRPF4B | 2.46520758 |
6 | NTRK3 | 2.14676918 |
7 | CLK1 | 2.11909863 |
8 | TNIK | 2.06672840 |
9 | NEK9 | 2.03232456 |
10 | FGFR3 | 1.95977769 |
11 | BLK | 1.82029467 |
12 | CDK19 | 1.80985324 |
13 | MAP2K7 | 1.79601161 |
14 | TYK2 | 1.79348550 |
15 | FGFR4 | 1.69431706 |
16 | DAPK2 | 1.68554202 |
17 | TLK1 | 1.61243399 |
18 | CDK12 | 1.60378519 |
19 | IRAK4 | 1.58912012 |
20 | MAP3K12 | 1.53391962 |
21 | ERN1 | 1.47766420 |
22 | MAP2K3 | 1.45651676 |
23 | TTN | 1.43081536 |
24 | SGK2 | 1.42353405 |
25 | MKNK1 | 1.41086837 |
26 | EEF2K | 1.40912412 |
27 | CDC42BPA | 1.38778453 |
28 | CCNB1 | 1.38449540 |
29 | OXSR1 | 1.35038343 |
30 | RIPK4 | 1.30646236 |
31 | RIPK1 | 1.28281463 |
32 | PDGFRA | 1.26712275 |
33 | ZAP70 | 1.24761393 |
34 | NLK | 1.24147399 |
35 | TXK | 1.24011704 |
36 | SGK494 | 1.23652611 |
37 | SGK223 | 1.23652611 |
38 | CAMKK2 | 1.23209225 |
39 | TRIB3 | 1.22460730 |
40 | AKT3 | 1.17822007 |
41 | MUSK | 1.10382781 |
42 | PDGFRB | 1.09894768 |
43 | DAPK1 | 1.09855401 |
44 | DDR2 | 1.05954884 |
45 | MAPKAPK3 | 1.04812527 |
46 | TNK2 | 1.01202790 |
47 | EPHA3 | 1.00997316 |
48 | PIK3CG | 1.00535078 |
49 | KSR2 | 0.99920876 |
50 | MAPK13 | 0.99059527 |
51 | PKN1 | 0.98480963 |
52 | TAOK3 | 0.98057410 |
53 | MARK2 | 0.98055432 |
54 | TBK1 | 0.97697240 |
55 | PLK2 | 0.97293952 |
56 | FRK | 0.96124788 |
57 | MAP3K3 | 0.95169729 |
58 | SGK3 | 0.94626797 |
59 | TEC | 0.94407631 |
60 | MYLK | 0.93886824 |
61 | YES1 | 0.92220900 |
62 | JAK3 | 0.91231158 |
63 | GRK7 | 0.90673591 |
64 | MAP3K14 | 0.89510217 |
65 | MAPKAPK5 | 0.88875550 |
66 | CAMK1 | 0.88041545 |
67 | MAP3K4 | 0.86723158 |
68 | WNK1 | 0.85815694 |
69 | KIT | 0.85766207 |
70 | JAK2 | 0.85360792 |
71 | MAPK11 | 0.83864742 |
72 | MAP3K2 | 0.83530386 |
73 | TGFBR2 | 0.82393224 |
74 | NEK6 | 0.82308535 |
75 | RET | 0.80378113 |
76 | SYK | 0.79351191 |
77 | MAP3K7 | 0.79305581 |
78 | CDK5 | 0.77129825 |
79 | MAP3K13 | 0.76947885 |
80 | PTK2B | 0.76917636 |
81 | CAMK2B | 0.76833476 |
82 | FER | 0.75497181 |
83 | ITK | 0.74886333 |
84 | MELK | 0.74070418 |
85 | TIE1 | 0.73882640 |
86 | STK10 | 0.73466164 |
87 | HIPK2 | 0.72354193 |
88 | CDK3 | 0.71239564 |
89 | STK11 | 0.70943423 |
90 | GRK1 | 0.69338827 |
91 | DAPK3 | 0.68501642 |
92 | MAPK12 | 0.66202099 |
93 | JAK1 | 0.65965431 |
94 | PIK3CA | 0.64733140 |
95 | SGK1 | 0.64322935 |
96 | PDK1 | 0.64283713 |
97 | HCK | 0.63871722 |
98 | CAMK1D | 0.63775993 |
99 | CAMK2A | 0.63198824 |
100 | UHMK1 | 0.62738325 |
101 | MOS | 0.61881511 |
102 | CSK | 0.61603238 |
103 | STK38 | 0.60430000 |
104 | CAMK4 | 0.60333208 |
105 | TRPM7 | 0.60029778 |
106 | INSRR | 0.59129285 |
107 | DMPK | 0.59094234 |
108 | MAP4K1 | 0.58587197 |
109 | EPHB1 | 0.57884197 |
110 | ROCK2 | 0.57543951 |
111 | IKBKB | 0.57436369 |
112 | PDPK1 | 0.57147007 |
113 | NTRK2 | 0.56493324 |
114 | CHUK | 0.56481713 |
115 | PAK2 | 0.56477348 |
116 | PRKD1 | 0.56371928 |
117 | MAPK15 | 0.55539865 |
118 | BMPR2 | 0.54853020 |
119 | LMTK2 | 0.54039117 |
120 | SIK3 | 0.53270419 |
121 | FGR | 0.52525835 |
122 | NTRK1 | 0.52269913 |
123 | STK39 | 0.51510076 |
124 | MAPK7 | 0.51281265 |
125 | PRKAA2 | 0.51002980 |
126 | PRKCE | 0.50888748 |
127 | MAP3K1 | 0.50635453 |
128 | EIF2AK2 | 0.50234252 |
129 | PRKD2 | 0.50191665 |
130 | IRAK1 | 0.49959810 |
131 | PHKG2 | 0.49098129 |
132 | PHKG1 | 0.49098129 |
133 | CAMK1G | 0.48537243 |
134 | * LCK | 0.47597042 |
135 | PRKCH | 0.46528535 |
136 | MTOR | 0.46009547 |
137 | CSF1R | 0.45971992 |
138 | FYN | 0.45263307 |
139 | IKBKE | 0.44830473 |
140 | MAP3K6 | 0.44704687 |
141 | BTK | 0.44484326 |
142 | PTK2 | 0.44358335 |
143 | MAP2K4 | 0.44049289 |
144 | STK16 | 0.44015064 |
145 | PRKG1 | 0.42887252 |
146 | MINK1 | 0.42708907 |
147 | PRKCQ | 0.42320238 |
148 | LYN | 0.41692212 |
149 | RPS6KA2 | 0.41281986 |
150 | SIK2 | 0.41074410 |
151 | MAPK4 | 0.40995508 |
152 | CAMKK1 | 0.40974465 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.77378818 |
2 | Morphine addiction_Homo sapiens_hsa05032 | 2.45424074 |
3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.23633377 |
4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.16104512 |
5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.07841946 |
6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.01751273 |
7 | Long-term potentiation_Homo sapiens_hsa04720 | 1.88182308 |
8 | Renin secretion_Homo sapiens_hsa04924 | 1.87010362 |
9 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.85226642 |
10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.84151543 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 1.76730783 |
12 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.65491914 |
13 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64709119 |
14 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.58119640 |
15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.56439373 |
16 | Long-term depression_Homo sapiens_hsa04730 | 1.55715753 |
17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49864727 |
18 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.48767434 |
19 | Taste transduction_Homo sapiens_hsa04742 | 1.48727667 |
20 | Allograft rejection_Homo sapiens_hsa05330 | 1.44847288 |
21 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.44585813 |
22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.43740644 |
23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.39744357 |
24 | Focal adhesion_Homo sapiens_hsa04510 | 1.38702876 |
25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37289295 |
26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.36094339 |
27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35109930 |
28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.34769531 |
29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.34639358 |
30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.34638269 |
31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.34617134 |
32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.34174817 |
33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32834845 |
34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27937770 |
35 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.27255195 |
36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.27034653 |
37 | Insulin secretion_Homo sapiens_hsa04911 | 1.26053845 |
38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.25136776 |
39 | Phototransduction_Homo sapiens_hsa04744 | 1.20028864 |
40 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.20014752 |
41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16857971 |
42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16565701 |
43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15581710 |
44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.13581580 |
45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.13007714 |
46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12518361 |
47 | Axon guidance_Homo sapiens_hsa04360 | 1.12306773 |
48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11513374 |
49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09259789 |
50 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.09220449 |
51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09016660 |
52 | Influenza A_Homo sapiens_hsa05164 | 1.08777635 |
53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08246890 |
54 | Measles_Homo sapiens_hsa05162 | 1.07244202 |
55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05878605 |
56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05159304 |
57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03307771 |
58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02979585 |
59 | Asthma_Homo sapiens_hsa05310 | 1.02653778 |
60 | Phagosome_Homo sapiens_hsa04145 | 1.01148039 |
61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99858137 |
62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99520458 |
63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99224303 |
64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98540025 |
65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.98512909 |
66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98240005 |
67 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98162718 |
68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.95955635 |
69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95582568 |
70 | Hepatitis B_Homo sapiens_hsa05161 | 0.94978567 |
71 | Platelet activation_Homo sapiens_hsa04611 | 0.94967276 |
72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94428263 |
73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93386859 |
74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93321499 |
75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93035153 |
76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92615754 |
77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92243617 |
78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.91497072 |
79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.91459407 |
80 | Amoebiasis_Homo sapiens_hsa05146 | 0.89118848 |
81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88598094 |
82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87741691 |
83 | Hepatitis C_Homo sapiens_hsa05160 | 0.86407009 |
84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85459622 |
85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85399828 |
86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85001030 |
87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84596030 |
88 | Leishmaniasis_Homo sapiens_hsa05140 | 0.84346234 |
89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.82830798 |
90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82715620 |
91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82695135 |
92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82516211 |
93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82042510 |
94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81795780 |
95 | Gap junction_Homo sapiens_hsa04540 | 0.80820853 |
96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80076166 |
97 | Tuberculosis_Homo sapiens_hsa05152 | 0.79531518 |
98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78360201 |
99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78347521 |
100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78329212 |
101 | Prostate cancer_Homo sapiens_hsa05215 | 0.76821482 |
102 | Insulin resistance_Homo sapiens_hsa04931 | 0.76553323 |
103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75828407 |
104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74784551 |
105 | Adherens junction_Homo sapiens_hsa04520 | 0.74457390 |
106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73088859 |
107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73053161 |
108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71813503 |
109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71623096 |
110 | Apoptosis_Homo sapiens_hsa04210 | 0.71157428 |
111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71137188 |
112 | Malaria_Homo sapiens_hsa05144 | 0.70906531 |
113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70679137 |
114 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.70648776 |
115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70431946 |
116 | Melanogenesis_Homo sapiens_hsa04916 | 0.69161494 |
117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68455293 |
118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68319940 |
119 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.68086100 |
120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66787744 |
121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66392563 |
122 | Pertussis_Homo sapiens_hsa05133 | 0.65905284 |
123 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65496787 |
124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65193101 |
125 | Glioma_Homo sapiens_hsa05214 | 0.64952939 |
126 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64459458 |
127 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63022496 |
128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61694107 |
129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61370705 |
130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60285567 |
131 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59771447 |
132 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59152345 |
133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59104185 |
134 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58147078 |
135 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57254584 |
136 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56734261 |
137 | Lysosome_Homo sapiens_hsa04142 | 0.56502147 |
138 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56126044 |
139 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.54123862 |
140 | Endocytosis_Homo sapiens_hsa04144 | 0.52596842 |
141 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52403192 |
142 | Salmonella infection_Homo sapiens_hsa05132 | 0.51812555 |
143 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50783047 |
144 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50375907 |
145 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50074842 |